David Miller, MD, PhD, FAAD
SESSIONS
S002 Updates in Cutaneous Oncology
Mar 27, 2026
•
9:00 AM - 12:00 PM
•
Mile High 3A
F011 What's New in the Management of Advanced Skin Cancer
Mar 27, 2026
•
1:00 PM - 3:00 PM
•
Bluebird 2D
DISCLOSURES
Almirall – Consultant (1099 relationship)(Fees); Avstera Therapeutics Corp – Advisory Board(Stock Options); Bristol Myers Squibb – Consultant (1099 relationship)(Fees); Castle Biosciences – Advisory Board(Fees); Checkpoint Therapeutics – Advisory Board(Honoraria), Advisory Board(Stock Options); Kartos Therapeutics – Investigator(Grants/Research Funding); Merck – Advisory Board(Honoraria); NeoImmuneTech – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); Xilio Therapeutics – Investigator(Grants/Research Funding);